GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 213.00
Bid: 213.00
Ask: 213.50
Change: -0.50 (-0.23%)
Spread: 0.50 (0.235%)
Open: 213.00
High: 214.50
Low: 213.00
Prev. Close: 213.50
TCAP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re acquisition

2 Feb 2016 07:00

RNS Number : 7435N
Tullett Prebon PLC
02 February 2016
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

FOR IMMEDIATE RELEASE

2 February 2016

 

 

Tullett Prebon plc

 

 

Update on the proposed acquisition of ICAP's global hybrid voice broking and information business

 

 

Further to the announcement regarding the proposed acquisition by Tullett Prebon of ICAP's global hybrid voice broking and information business released on 11 November 2015 (the "Announcement"), Tullett Prebon is updating shareholders in relation to the clearance sought from the United States Department of Justice (the "DOJ") in connection with the Transaction. Terms defined in the Announcement have the same meanings in this announcement.

 

Tullett Prebon has received a request for additional information and documentary material from the DOJ in connection with the Transaction. This form of request from the DOJ, often referred to as a "Second Request", is part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). Tullett Prebon understands that the DOJ's review is focused on the proposed post completion shareholding and governance arrangements between Tullett Prebon and ICAP Newco.

 

The effect of the Second Request is to extend the waiting period imposed by the HSR Act until 30 days after Tullett Prebon and ICAP have substantially complied with the Second Request, unless that period is extended voluntarily by the companies or terminated earlier. Tullett Prebon intends to respond to the request from the DOJ as quickly as practicable and to continue to work cooperatively with the DOJ in connection with its review of the Transaction.

 

Completion of the Transaction remains subject to the approval of Tullett Prebon shareholders, the approval of ICAP shareholders, clearance from the Competition and Markets Authority ("CMA"), expiration or termination of all applicable waiting periods under the HSR Act, clearance from certain other antitrust authorities, approval by various regulatory bodies including the FCA, and satisfaction of other customary closing conditions noted in the Announcement.

 

Tullett Prebon continues to anticipate that the Transaction will close in 2016.

 

 

Enquiries

Stephen Breslin

Group Head of Communications, Tullett Prebon plc

Direct: +44 (0) 20 7200 7750

Email: sbreslin@tullettprebon.com

Craig Breheny

Brunswick Group LLP

Direct: +44 (0) 20 7396 7429

Email: cbreheny@brunswickgroup.com

 

 

 

Important notice

This announcement has been issued by and is the sole responsibility of Tullett Prebon.

 

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities pursuant to this announcement or otherwise. The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

 

This announcement does not constitute an offer of securities for sale in the United States or an offer to acquire or exchange securities in the United States. No offer to acquire securities or to exchange securities for other securities has been made, or will be made, and no offer of securities has been made, or will be made, directly or indirectly, in or into, or by use of the mails, any means or instrumentality of interstate or foreign commerce or any facilities of a national securities exchange of, the United States of America or any other country in which such offer may not be made other than (i) in accordance with the requirements under the US Securities Exchange Act of 1934, as amended, a registration statement under the US Securities Act of 1933, as amended, or the securities laws of such other country, as the case may be, or (ii) pursuant to an available exemption therefrom. No securities are intended to be registered under the US Securities Act of 1933, as amended.

 

This announcement has been prepared for the purposes of complying with the applicable law and regulation of the United Kingdom (including the Listing Rules and the Disclosure and Transparency Rules) and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

 

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect Tullett Prebon's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to Tullett Prebon's results of operations, financial position, liquidity, prospects, growth or strategies and the industry in which Tullett Prebon operates. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. Save as required by law or regulation, Tullett Prebon disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect events or circumstances after the date of this announcement.

 

Except as explicitly stated, neither the content of Tullett Prebon's website, nor any website accessible by hyperlinks on Tullett Prebon's website is incorporated in, or forms part of, this announcement.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRAKBDQABKKOBK
Date   Source Headline
14th Mar 20237:00 amRNSTP ICAP Group PLC - Final Results
8th Feb 20234:19 pmRNSChanges to Senior Independent Director
13th Dec 202210:00 amRNSHolding(s) in Company
6th Dec 20225:15 pmRNSHolding(s) in Company
1st Nov 20227:00 amRNSTrading Statement
27th Oct 20225:30 pmRNSHolding(s) in Company
25th Oct 20225:50 pmRNSHolding(s) in Company
13th Sep 20225:32 pmRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
28th Jul 20225:22 pmRNSResult of External Audit Tender
30th Jun 20225:44 pmRNSHolding(s) in Company
27th May 20223:30 pmRNSDirector/PDMR Shareholding
11th May 20226:01 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
4th May 20224:27 pmRNSGrant of Options and Director/PDMR Shareholding
22nd Apr 20224:49 pmRNSHolding(s) in Company
11th Apr 20224:17 pmRNSHolding(s) in Company
5th Apr 202211:02 amRNSAnnual Financial Report
4th Apr 20224:03 pmRNSDirector/PDMR Shareholding
31st Mar 20226:03 pmRNSDirector/PDMR Shareholding
29th Mar 20225:44 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSFinal Results
11th Jan 202211:35 amRNSHolding(s) in Company
22nd Dec 20215:00 pmRNSAppointment of new director
13th Dec 20213:24 pmRNSDirector/PDMR Shareholding
12th Nov 20212:04 pmRNSShareholder meeting update and PDMR transactions
12th Nov 20211:57 pmRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading update - three months ended 30/09/2021
11th Oct 20214:00 pmRNSDirector/PDMR Shareholding
11th Oct 20213:01 pmRNSParameta Solutions Investor Seminar
7th Oct 202110:40 amRNSDirector/PDMR Shareholding
20th Sep 20214:58 pmRNSDirector/PDMR Shareholding
8th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20217:00 amRNSTrading Statement
22nd Jun 20214:36 pmRNSDirector/PDMR Shareholding
18th May 202111:20 amRNSDirector/PDMR Shareholding
12th May 20215:49 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
23rd Apr 20215:10 pmRNSGrant of Options and Director/PDMR Shareholding
6th Apr 20214:32 pmRNSDirector/PDMR Shareholding - Replacement
1st Apr 20216:15 pmRNSDirector/PDMR Shareholding
26th Mar 20212:05 pmRNSAnnual Financial Report
10th Mar 20215:16 pmRNSRe-registration and name change
9th Mar 20217:03 amRNSFinal Results
26th Feb 20218:24 amRNSScheme Effective and Admission
24th Feb 20214:24 pmRNSCourt Sanction of the Scheme of Arrangement
18th Feb 20214:20 pmRNSHolding(s) in Company
17th Feb 20214:00 pmRNSDirector/PDMR Shareholding
17th Feb 20214:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.